Novel and Investigational Drugs in Depression

Journal Title: International Neuropsychiatric Disease Journal - Year 2014, Vol 2, Issue 6

Abstract

Major depressive disorder is a serious medical illness associated with significant burden. Our current treatments for depression are limited, which has motivated researchers to explore novel targets. This article will highlight new psychopharmacological agents and investigational directions which may show promise in achieving better outcomes and symptom relief for those suffering from depression. This review will address key categories of novel therapeutic targets for depression. The newer and investigational agents involving monoaminergic transmission will be discussed, followed by those with glutamatergic, opioid, anticholinergic, and miscellaneous mechanisms. As the field continues to learn more about the pathophysiology of depression, there will be an emergence of additional innovative targets and investigational mechanisms, along with an improvement in our treatment outcomes.

Authors and Affiliations

Desiree N. Shapiro, Stephen M. Stahl

Keywords

Related Articles

Correlations between the Serum Antibody Levels to Herpes Family Viruses and Multi-parametric Immunity Characteristics with Clinical Symptoms in Episodic Remittent form of Paranoid Schizophrenia

Background: Recent etiological studies for schizophrenia have been focused on the herpes family viruses. The majority of these studies were aimed at detection of increased specific antibodies level. An important aspect o...

Resveratrol Reduces C-reactive Protein and Cholesterol in Schizophrenia

Patients with schizophrenia (SZ) are generally found with overweight and obesity and several metabolic disorders. Additionally these patients have less life expectancy, with cardiovascular disease (CVD) the main cause of...

Quality of Life of Palestine Children Exposed to Wars in Gaza

Aim: This study aimed to investigate the impact of trauma due to wars on quality of life of Palestine children living in Gaza with special reference to 2009 war. It is analytic study; the study sample consisted of 195 ch...

Practice Guidelines for Treatment of Somatic Pain and Depression

Background: Somatic pain is often associated with depression. Patients presenting with this combination can be difficult to treat and create a significant financial burden on the medical system. The mechanisms of action...

Mindfulness, Sexual Functioning, and Subjective Sexual Well-Being

Although there are several studies that address mindfulness, sexual functioning, and subjective sexual well-being separately, there are very few studies that explore the associations between these three constructs. There...

Download PDF file
  • EP ID EP241607
  • DOI 10.9734/INDJ/2014/11590
  • Views 96
  • Downloads 0

How To Cite

Desiree N. Shapiro, Stephen M. Stahl (2014). Novel and Investigational Drugs in Depression. International Neuropsychiatric Disease Journal, 2(6), 328-347. https://europub.co.uk/articles/-A-241607